CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway.

Sci Rep · 2026 · PMC13133128 · PMID 41844740

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendp = 0.055so close (0.05 < p ≤ 0.1)

Although no variables reached statistical significance, CHD1L expression showed a trend toward association with advanced pathologic T stage ( p = 0.055), history of undescended testis ( p = 0.058), and lymphovascular invasion ( p = 0.095).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.